Skip to main content
. 2020 Jul 14;6:37. doi: 10.1186/s40729-020-00226-6

Table 2.

Clinical parameters (mean ± SD, median, and 95% CI)

Clinical parameters Control group
(mean ± SD)
Median 95% CI Test group
(mean ± SD)
Median 95% CI p
Modified plaque index
 Patient-level 0.46 ± 0.43 0.33 0.38–0.54 0.49 ± 0.42 0.50 0.41–0.57 0.56
 Implant-level 0.49 ± 0.41 0.33 0.44–0.54 0.51 ± 0.43 0.50 0.46–0.56 0.51
Bleeding on probing (%)
 Patient-level 33.07 ± 30.37 33 27.36–38.79 32.26 ± 30.88 17 26.71–37.82 0.084
 Implant-level 36.77 ± 32.23 33 33–40.10 35.53 ± 32.67 33 31.76–39.30 0.648
Probing depth (mm)
 Patient-level 3.0 ± 0.72 2.83 2.86-3.13 2.86 ± 0.96 2.67 2.68-3.03 0.22
 Implant-level 3.0 ± 0.85 2.83 2.90–3.11 2.78 ± 0.86 2.67 2.68–2.88 0.002
Mucosal recession (mm)
 Patient-level 0.17 ± 0.34 0 0.10–0.23 0.18 ± 0.36 0 0.11–0.24 0.79
 Implant-level 0.16 ± 0.36 0 0.12–0.20 0.19 ± 0.36 0 0.16–0.24 0.221